Suchergebnisse - "Hasegawa, Tetsuya"

PubPharm (209)

31

Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone : Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid in vitro

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2021

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +3

32

Room-Temperature Antiferroelectricity in Multiferroic Hexagonal Rare-Earth Ferrites

enthalten in: ACS applied materials & interfaces | 2021

von Kasahara, J. | Katayama, T. | Mo, S. | +5

33

Total Anthocyanin Content, Total Phenolic Content, and Antioxidant Activity of Various Blueberry Cultivars Grown in Togane, Chiba Prefecture, Japan

enthalten in: Journal of nutritional science and vitaminology | 2021

von Shibata, Y. | Ohara, K. | Matsumoto, K. | +2

34

Evaluation of the Foveal Avascular Zone in Familial Exudative Vitreoretinopathy Using Optical Coherence Tomography Angiography

enthalten in: Clinical ophthalmology (Auckland, N.Z.) | 2021

von Hasegawa, T. | Hirato, M. | Kobashi, C. | +5

35

Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer–Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acidin vitro

enthalten in: Xenobiotica | 2021

von Matsumoto, K. | Hasegawa, T. | Ohara, K. | +3

36

Strain-induced creation and switching of anion vacancy layers in perovskite oxynitrides

enthalten in: Nature communications | 2020

von Yamamoto, T. | Chikamatsu, A. | Kitagawa, S. | +25

37

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

enthalten in: Europäisches Patentamt | 2020

von GABAZZA ESTEBAN C | KOBAYASHI TETSU | TOYOBUKU HIDEKAZU | +2

38

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

enthalten in: Europäisches Patentamt | 2020

von GABAZZA ESTEBAN C | KOBAYASHI TETSU | TOYOBUKU HIDEKAZU | +2

39

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

enthalten in: Europäisches Patentamt | 2020

von GABAZZA ESTEBAN C | KOBAYASHI TETSU | TOYOBUKU HIDEKAZU | +2

40

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

enthalten in: Europäisches Patentamt | 2020

von GABAZZA ESTEBAN C | KOBAYASHI TETSU | TOYOBUKU HIDEKAZU | +2